SAN

76.74

+2.12%↑

ARGX

687.2

+0.23%↑

SHL.DE

34.31

+1%↑

FRE

40.16

+1.24%↑

PHIA

22.99

+2.18%↑

SAN

76.74

+2.12%↑

ARGX

687.2

+0.23%↑

SHL.DE

34.31

+1%↑

FRE

40.16

+1.24%↑

PHIA

22.99

+2.18%↑

SAN

76.74

+2.12%↑

ARGX

687.2

+0.23%↑

SHL.DE

34.31

+1%↑

FRE

40.16

+1.24%↑

PHIA

22.99

+2.18%↑

SAN

76.74

+2.12%↑

ARGX

687.2

+0.23%↑

SHL.DE

34.31

+1%↑

FRE

40.16

+1.24%↑

PHIA

22.99

+2.18%↑

SAN

76.74

+2.12%↑

ARGX

687.2

+0.23%↑

SHL.DE

34.31

+1%↑

FRE

40.16

+1.24%↑

PHIA

22.99

+2.18%↑

Начало・Списък с акции・Nanobiotix

N
Nanobiotix

Затворен

36.8 -4.37

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

35.38

Максимум

38.48

Ключови измерители
By Trading Economics
Приходи	-13M -19M
Продажби	-24M 3M
Марж на печалбата	-618.236
Служители	100
EBITDA	-14M -13M

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+55.93% upside

Дивиденти
By Dow Jones
Следващи печалби	27.05.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	592M 1.9B
Предишно отваряне	41.17
Предишно затваряне	36.8

Техническа оценка

By Trading Central

Увереност

Very Strong Bullish Evidence

2.975 / 3.015 Подкрепа & съпротива

Nanobiotix Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

20.05.2026 г., 23:31 ч. UTC

Горещи акции

Stocks to Watch: Intuit, Applied Digital, Osisko, Banzai

20.05.2026 г., 22:52 ч. UTC

Значими двигатели на пазара

Osisko Shares Fall on Planned Convertible Notes Offering

20.05.2026 г., 23:47 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

20.05.2026 г., 23:47 ч. UTC

Пазарно говорене

Nikkei May Rise on Continued AI Enthusiasm -- Market Talk

20.05.2026 г., 23:44 ч. UTC

Печалби

Musk Is In Total Control of SpaceX. The IPO Filing Has Finally Come. -- Barrons.com

20.05.2026 г., 23:35 ч. UTC

Пазарно говорене

Gold Edges Lower Amid Slightly Higher U.S. Treasury Yields -- Market Talk

20.05.2026 г., 23:30 ч. UTC

Пазарно говорене

Goodman Well-Placed for Earnings Guidance Upgrade -- Market Talk

20.05.2026 г., 23:17 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

20.05.2026 г., 23:17 ч. UTC

Пазарно говорене

Ryman Healthcare Bull Focusing on Three Areas in FY26 Result -- Market Talk

20.05.2026 г., 23:15 ч. UTC

Пазарно говорене

Mainfreight's FY26 Profit Fall May Mask Improving Performance -- Market Talk

20.05.2026 г., 23:14 ч. UTC

Печалби

Nvidia Rides Blistering Chip Sales to Another Record Quarter -- 4th Update

20.05.2026 г., 23:02 ч. UTC

Пазарно говорене

KMD Brands Faces Two Testing Hurdles -- Market Talk

20.05.2026 г., 22:57 ч. UTC

Пазарно говорене

Infratil's Other Assets Deserve Attention, Too -- Market Talk

20.05.2026 г., 22:57 ч. UTC

Пазарно говорене

Global Energy Roundup: Market Talk

20.05.2026 г., 22:57 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

20.05.2026 г., 22:51 ч. UTC

Пазарно говорене

Australia Shares Set to Rise, Continue Whipsaw Week -- Market Talk

20.05.2026 г., 22:51 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

20.05.2026 г., 22:27 ч. UTC

Пазарно говорене

SpaceX Says It Has Largest Addressable Market in 'Human History' -- Market Talk

20.05.2026 г., 22:14 ч. UTC

Пазарно говорене

Moody's Downgrades Mexico's Sovereign Rating -- Market Talk

20.05.2026 г., 22:10 ч. UTC

Печалби

Nvidia Rides Blistering Chip Sales to Another Record Quarter -- 3rd Update

20.05.2026 г., 22:00 ч. UTC

Печалби

Intuit Stock Falls on Earnings -- and the Company Plans to Cut 17% of Its Workforce -- Barrons.com

20.05.2026 г., 21:38 ч. UTC

Печалби

Придобивния, сливания и поглъщания

Nvidia Rides Blistering Chip Sales to Another Record Quarter -- 2nd Update

20.05.2026 г., 21:27 ч. UTC

Печалби

Nvidia Rides Blistering Chip Sales to Another Record Quarter -- Update

20.05.2026 г., 21:20 ч. UTC

Печалби

Nvidia CFO: Edge Computing Demand Fell Modestly Due to Higher Memory Prices

20.05.2026 г., 21:19 ч. UTC

Печалби

Nvidia Still Uncertain Whether Shipping to China Will Be Allowed, CFO Says

20.05.2026 г., 21:18 ч. UTC

Печалби

Nvidia on Track to Start Production Shipments of Vera Rubin in Second Half of This Year, CFO Says

20.05.2026 г., 21:17 ч. UTC

Печалби

Nvidia Projects $20B in CPU Revenue This Year, CFO Says

20.05.2026 г., 21:17 ч. UTC

Печалби

Nvidia CFO: Every Major Hyperscaler Engaged in Deploying Vera CPU

20.05.2026 г., 21:17 ч. UTC

Печалби

Nvidia's Vera CPU Opens New $200B Market, CFO Says

20.05.2026 г., 21:16 ч. UTC

Печалби

SpaceX IPO Filing Finally Comes. Mars, Musk, and More Big Things to Watch. -- Barrons.com

Сравнение с други в отрасъла

Ценова промяна

Nanobiotix Прогноза

Ценова цел

By TipRanks

55.93% нагоре

12-месечна прогноза

Среден 60 EUR 55.93%

Висок 60 EUR

Нисък 60 EUR

Според 1 анализатори от Wall Street, предложили 12-месечна ценова цел за Nanobiotix през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

1 ratings

Купи

Задържане

Продай

Според 1 анализатори, дали борсови рейтинги на Nanobiotix през последните 3 месеца.

Техническа оценка

By Trading Central

2.975 / 3.015Подкрепа & съпротива

Recent bullish events outweigh bearish events.

Bearish events outweigh bullish events.

There is one bearish event.

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Nanobiotix

Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is headquartered in Paris, France.